Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


05.02.2024

1 Abdom Radiol (NY)
1 Acta Obstet Gynecol Scand
1 Am J Hum Genet
1 Am J Obstet Gynecol
1 Anticancer Agents Med Chem
1 Anticancer Res
2 Asian Pac J Cancer Prev
1 bioRxiv
1 Biosci Rep
1 BMB Rep
2 BMC Cancer
1 BMC Complement Med Ther
1 BMC Med Imaging
4 BMC Womens Health
1 BMJ Case Rep
1 Cancer
2 Cancer Causes Control
2 Cancer Sci
1 Cell Signal
2 Cureus
1 Curr Med Chem
1 Diagn Pathol
1 East Mediterr Health J
1 Emerg Med Int
2 Eur J Cancer Prev
1 Eur J Obstet Gynecol Reprod Biol
1 Eur Rev Med Pharmacol Sci
2 Exp Cell Res
1 Fam Med Community Health
1 Free Radic Biol Med
1 Front Biosci (Landmark Ed)
1 Front Public Health
1 Genes (Basel)
1 Genet Test Mol Biomarkers
2 Gynecol Oncol
4 Heliyon
1 Infect Disord Drug Targets
1 Int J Mol Sci
1 J Antibiot (Tokyo)
1 J Cancer Res Clin Oncol
1 J Clin Lab Anal
1 J Exp Clin Cancer Res
1 J Gynecol Oncol
1 J Med Virol
2 JNMA J Nepal Med Assoc
1 Med Oncol
1 Nature
1 Oncology (Williston Park)
1 Prev Med
1 Prev Med Rep
2 Psychooncology
1 Reprod Sci
1 RSC Adv
1 Sci Rep
1 Strahlenther Onkol
1 Viruses
1 Wiad Lek
1 Womens Health (Lond)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. SONG J, Pang W, Yi H, Ji J, et al
    Tumor and metastatic lymph nodes metabolic activity on (18)F-FDG-PET/CT to predict progression-free survival in locally advanced cervical cancer.
    Abdom Radiol (NY). 2024 Feb 1. doi: 10.1007/s00261-023-04158.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  2. LINDROTH Y, Pedersen L, Alssamaray J, Berglund T, et al
    Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
    Acta Obstet Gynecol Scand. 2024;103:378-386.
    PubMed         Abstract available


    Am J Hum Genet

  3. RODRIGUEZ I, Rossi NM, Keskus AG, Xie Y, et al
    Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing.
    Am J Hum Genet. 2024 Jan 25:S0002-9297(24)00002.
    PubMed         Abstract available


    Am J Obstet Gynecol

  4. WHEELER CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, et al
    Comparing the performance of two HPV assays for a new use indication: a real-world evidence-based evaluation in the United States.
    Am J Obstet Gynecol. 2023 Oct 6:S0002-9378(23)00730.
    PubMed         Abstract available


    Anticancer Agents Med Chem

  5. SARASWAT I, Goel A
    Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles.
    Anticancer Agents Med Chem. 2024.
    PubMed         Abstract available


    Anticancer Res

  6. BRAUTIGAM K, Schmidt T, Baur M, Tauber N, et al
    Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
    Anticancer Res. 2024;44:503-510.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  7. THAKUR N, Kaur H, Kaur S, Lehal P, et al
    Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
    Asian Pac J Cancer Prev. 2024;25:139-144.
    PubMed         Abstract available

  8. KITTISIAM T, Chanpanitkitchot S, Tangjitgamol S, Srijaipracharoen S, et al
    Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer.
    Asian Pac J Cancer Prev. 2024;25:211-217.
    PubMed         Abstract available


    bioRxiv

  9. PATTERSON MR, Meijers AS, Ryder EL, Scarth JA, et al
    E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    bioRxiv. 2024 Jan 15:2024.01.08.574687. doi: 10.1101/2024.01.08.574687.
    PubMed         Abstract available


    Biosci Rep


  10. Retraction: LINC00636 promotes lymph node metastasis and of cervical cancer through target NM23.
    Biosci Rep. 2024;44:BSR-2020-0367.
    PubMed        


    BMB Rep

  11. JUNG BC, Woo SH, Kim SH, Kim YS, et al
    Gefitinib induces anoikis in cervical cancer cells.
    BMB Rep. 2024 Feb 5:6127.
    PubMed         Abstract available


    BMC Cancer

  12. LIU H, Cui Y, Chang C, Zhou Z, et al
    Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
    BMC Cancer. 2024;24:150.
    PubMed         Abstract available

  13. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
    Sociodemographic characteristics and their association with survival in women with cervical cancer.
    BMC Cancer. 2024;24:161.
    PubMed         Abstract available


    BMC Complement Med Ther

  14. LE-TRUNG N, Kanaori K, Waku T, Dang TTP, et al
    Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
    BMC Complement Med Ther. 2024;24:59.
    PubMed         Abstract available


    BMC Med Imaging

  15. WU Q, Lou J, Liu J, Dong L, et al
    Performance of node reporting and data system (node-RADS): a preliminary study in cervical cancer.
    BMC Med Imaging. 2024;24:28.
    PubMed         Abstract available


    BMC Womens Health

  16. EVINA BOLO S, Kenfack B, Wisniak A, Tankeu G, et al
    Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study.
    BMC Womens Health. 2024;24:76.
    PubMed         Abstract available

  17. CHEN Q, Zhao J, Xue X, Xie X, et al
    Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database.
    BMC Womens Health. 2024;24:75.
    PubMed         Abstract available

  18. MA GF, Lin GL, Wang ST, Huang YY, et al
    Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
    BMC Womens Health. 2024;24:81.
    PubMed         Abstract available

  19. AZANGOU-KHYAVY M, Ghasemi E, Rezaei N, Khanali J, et al
    Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990-2019.
    BMC Womens Health. 2024;24:69.
    PubMed         Abstract available


    BMJ Case Rep

  20. CASANOVA C, Madeira JIM, Pereira da Silva N, Antunes C, et al
    Post-radiation uterine rhabdomyosarcoma.
    BMJ Case Rep. 2024;17:e258853.
    PubMed        


    Cancer

  21. KNISELY A, Ahmed J, Stephen B, Piha-Paul SA, et al
    Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
    Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
    PubMed         Abstract available


    Cancer Causes Control

  22. BERZANSKY I, Reynolds CA, Charlton BM
    Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Cancer Causes Control. 2024 Jan 27. doi: 10.1007/s10552-023-01847.
    PubMed         Abstract available

  23. MONDRAGON MARQUEZ LI, Dominguez Bueso DL, Gonzalez Ruiz LM, Liu JJ, et al
    Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Cancer Causes Control. 2023;34:1073-1084.
    PubMed         Abstract available


    Cancer Sci

  24. TOYOHARA Y, Taguchi A, Ishii Y, Yoshimoto D, et al
    Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.
    Cancer Sci. 2024;115:125-138.
    PubMed         Abstract available

  25. BIKORIMANA JP, Abusarah J, Goncalves M, Farah R, et al
    An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
    Cancer Sci. 2024 Jan 29. doi: 10.1111/cas.16096.
    PubMed         Abstract available


    Cell Signal

  26. GONG Y, Luo G, Zhang S, Chen Y, et al
    Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Cell Signal. 2024 Jan 27:111068. doi: 10.1016/j.cellsig.2024.111068.
    PubMed         Abstract available


    Cureus

  27. SINGARAM NK, Hulikal N, Manthri R, Chowhan AK, et al
    Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.
    Cureus. 2024;16:e53107.
    PubMed         Abstract available

  28. ALSHEHRI HD, Alqudah O, Almadani FB, Aldalbahi AM, et al
    Factors Associated With the Uptake of Cervical Cancer Screening Among Family Medicine Physicians, Compared With Women of the Community in Riyadh, Saudi Arabia.
    Cureus. 2024;16:e53283.
    PubMed         Abstract available


    Curr Med Chem

  29. TRIPATHI T, Yadav J, Janjua D, Chaudhary A, et al
    Targeting Cervical Cancer Stem Cells by Phytochemicals.
    Curr Med Chem. 2024 Jan 29. doi: 10.2174/0109298673281823231222065616.
    PubMed         Abstract available


    Diagn Pathol

  30. QIN Y, Deng J, Ling Y, Chen T, et al
    Our experience diagnosing 225 patients with cervical glandular lesions: current technologies, lessons learned, and areas for improvement.
    Diagn Pathol. 2024;19:22.
    PubMed         Abstract available


    East Mediterr Health J

  31. JARAMILLO L, Camussi E, Dotti M, Ferrante G, et al
    EuroMed Cancer Network contributions to eliminating cervical cancer in low- and middle-income Mediterranean countries.
    East Mediterr Health J. 2023;26:894-902.
    PubMed         Abstract available


    Emerg Med Int

  32. INTERNATIONAL EM
    Retracted: Analysis of the Clinical Value of MAGE-A9 Expressions in Cervical Cancer Tissues and PBMC.
    Emerg Med Int. 2024;2024:9758570.
    PubMed         Abstract available


    Eur J Cancer Prev

  33. KELLEN E, Meers Z, Pil L, Goossens MC, et al
    Impact of altering the invitation package on screening participation among never-screeners in the Flemish population-based cancer screening programs.
    Eur J Cancer Prev. 2024;33:181-184.
    PubMed         Abstract available

  34. SLAMA J, Dvorak V, Trnkova M, Skrivanek A, et al
    Is phased implementation of HPV testing and triage with dual staining the way to transform organized cytology screening?
    Eur J Cancer Prev. 2024;33:168-176.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  35. WU J, Wang R, Chen W, Wu Y, et al
    Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:210-216.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  36. GU LN, Yu JW, Jiang L, Liu TB, et al
    Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Eur Rev Med Pharmacol Sci. 2024;28:668-678.
    PubMed         Abstract available


    Exp Cell Res

  37. LI Z, Zhang J, You S, Zhang J, et al
    Pterostilbene upregulates MICA/B via the PI3K/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells.
    Exp Cell Res. 2024;435:113933.
    PubMed         Abstract available

  38. QUAN Y, Zhou M, Li J, Yang Y, et al
    The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.
    Exp Cell Res. 2024 Jan 25:113924. doi: 10.1016/j.yexcr.2024.113924.
    PubMed         Abstract available


    Fam Med Community Health

  39. GORI S, Frayle H, Pagan A, Solda M, et al
    Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
    Fam Med Community Health. 2024;12.
    PubMed         Abstract available


    Free Radic Biol Med

  40. JIA C, Wu Y, Gao F, Liu W, et al
    The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions.
    Free Radic Biol Med. 2024 Jan 31:S0891-5849(24)00051.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  41. VARGAS-SIERRA O, Hernandez-Juarez J, Uc-Uc PY, Herrera LA, et al
    Role of SLC5A8 as a Tumor Suppressor in Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:16.
    PubMed         Abstract available


    Front Public Health

  42. FOKOM DOMGUE J, Dille I, Kapambwe S, Yu R, et al
    HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Front Public Health. 2024;12:1343064.
    PubMed         Abstract available


    Genes (Basel)

  43. LI J, Xi J
    Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Genes (Basel). 2024;15:121.
    PubMed         Abstract available


    Genet Test Mol Biomarkers

  44. ZHANG YT, Xu LJ, Li L
    EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment.
    Genet Test Mol Biomarkers. 2024;28:10-21.
    PubMed         Abstract available


    Gynecol Oncol

  45. DORISMOND VG, Saraiya M, Gopalani SV, Soman A, et al
    Variation in cervical cancer screening test utilization and results in a United States-based program.
    Gynecol Oncol. 2024;184:96-102.
    PubMed         Abstract available

  46. BEFANO B, Wentzensen N, Lorey T, Poitras N, et al
    Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
    Gynecol Oncol. 2024;184:89-95.
    PubMed         Abstract available


    Heliyon

  47. LIN S, Chen Z, Li S, Chen B, et al
    Anti-tumor effect and mechanism of the total biflavonoid extract from S doederleinii on human cervical cancer cells in vitro and in vivo.
    Heliyon. 2024;10:e24778.
    PubMed         Abstract available

  48. LI Z, Wei R, Yao S, Meng F, et al
    HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer.
    Heliyon. 2024;10:e24664.
    PubMed         Abstract available

  49. HUANG Z, Yao W, Zhong Z, Yang G, et al
    Chemotherapy alone versus chemotherapy plus (125)I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis.
    Heliyon. 2024;10:e24666.
    PubMed         Abstract available

  50. WANG X, Wang K, Wang X
    NUPR1 contributes to activate TFE3-dependent autophagy leading to cervical cancer proliferation.
    Heliyon. 2024;10:e24408.
    PubMed         Abstract available


    Infect Disord Drug Targets

  51. DARVISHI M, Nouri M, Zahir M, Asli M, et al
    Overview of Human Papillomavirus Infection.
    Infect Disord Drug Targets. 2024;24:e031123223107.
    PubMed         Abstract available


    Int J Mol Sci

  52. OKAYAMA K, Kakinuma M, Teruya K, Oda M, et al
    Predictive Value of Various Atypical Cells for the Detection of Human Papillomavirus in Cervical Smears.
    Int J Mol Sci. 2024;25:1212.
    PubMed         Abstract available


    J Antibiot (Tokyo)

  53. YU Y, Yu J, Cui X, Sun X, et al
    TNF-alpha-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin.
    J Antibiot (Tokyo). 2024;77:102-110.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  54. WANG J, Wang X, Ma T, Lu Y, et al
    A visualization analysis of hotspots and global trends on pelvic floor dysfunction in cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:54.
    PubMed         Abstract available


    J Clin Lab Anal

  55. NIE L, Qin H, Li S, Yu Z, et al
    The establishment of a multiplex fluorescent polymerase chain reaction coupled with capillary electrophoresis analysis technology enables the simultaneous detection of 16 genotypes of human papillomavirus.
    J Clin Lab Anal. 2024;38.
    PubMed         Abstract available


    J Exp Clin Cancer Res

  56. MENG Q, Sun H, Zhang Y, Yang X, et al
    Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.
    J Exp Clin Cancer Res. 2024;43:36.
    PubMed         Abstract available


    J Gynecol Oncol

  57. ANG DJM, Chan JJ
    Evolving standards and future directions for systemic therapies in cervical cancer.
    J Gynecol Oncol. 2024 Jan 15. doi: 10.3802/jgo.2024.
    PubMed         Abstract available


    J Med Virol

  58. BARTOSIK M, Moranova L, Izadi N, Strmiskova J, et al
    Advanced technologies towards improved HPV diagnostics.
    J Med Virol. 2024;96:e29409.
    PubMed         Abstract available


    JNMA J Nepal Med Assoc

  59. AMATYA VAIDYA S, Roka Magar L, Magar SB
    Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:658-661.
    PubMed         Abstract available

  60. SAPKOTA RP, Pokhrel S, Bhandari A, Adhikari P, et al
    Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient Department of Gynaecology of a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:699-702.
    PubMed         Abstract available


    Med Oncol

  61. HA JL, Kaser E, Guan T, Mayberry TG, et al
    Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
    Med Oncol. 2024;41:65.
    PubMed         Abstract available


    Nature

  62. DENNY L, Kataria I, Huang L, Schmeler KM, et al
    Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.
    Nature. 2024;626:30-32.
    PubMed        


    Oncology (Williston Park)

  63. LA SPINA S, Scollo P, Pecorino B, Lombardo V, et al
    Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
    Oncology (Williston Park). 2024;38:15-19.
    PubMed         Abstract available


    Prev Med

  64. DESAI KT, Hansen N, Rodriguez AC, Befano B, et al
    Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.
    Prev Med. 2024;180:107881.
    PubMed         Abstract available


    Prev Med Rep

  65. PRATT R, Barsness CB, Lin J, Desai J, et al
    Integrating HPV self-collect into primary care to address cervical cancer screening disparities.
    Prev Med Rep. 2024;38:102599.
    PubMed         Abstract available


    Psychooncology

  66. JIBOC NM, Pasca A, Taut D, Baban AS, et al
    Factors influencing human papillomavirus vaccination uptake in European women and adolescents: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6242.
    PubMed         Abstract available

  67. AL-ANI A, Hammouri M, Sultan H, Al-Huneidy L, et al
    Factors affecting cervical screening using the health belief model during the last decade: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6275.
    PubMed         Abstract available


    Reprod Sci

  68. WANG S, Zhang S
    A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Reprod Sci. 2024;31:514-531.
    PubMed         Abstract available


    RSC Adv

  69. BHATTACHARYA K, Chandra Nath B, Ahmed E, Khanal P, et al
    Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer.
    RSC Adv. 2024;14:4188-4200.
    PubMed         Abstract available


    Sci Rep

  70. ASSEFA AA, Feleke T, G/Tsadik SA, Degela F, et al
    Utilization and associated factors of cervical cancer screening service among eligible women attending maternal health services at Adare General Hospital, Hawassa city, Southern Ethiopia.
    Sci Rep. 2024;14:2774.
    PubMed         Abstract available


    Strahlenther Onkol

  71. ALFRINK J, Aigner T, Zoche H, Distel L, et al
    Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures.
    Strahlenther Onkol. 2024 Jan 31. doi: 10.1007/s00066-023-02196.
    PubMed         Abstract available


    Viruses

  72. MURAHWA AT, Mudzviti T, Mandishora RSD, Chatindo T, et al
    Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
    Viruses. 2024;16:162.
    PubMed         Abstract available


    Wiad Lek

  73. VOVK CAPITAL O, CYRILLICY, Holovanova IA, Podvin A, Popovuch IU, et al
    CONTEXTUAL FACTORS ASSOCIATED WITH CERVICAL CANCER.
    Wiad Lek. 2023;76:2687-2693.
    PubMed         Abstract available


    Womens Health (Lond)

  74. ALBAYAT SS, Mundodan JM, Elmardi K, Hasnain S, et al
    Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.
    Womens Health (Lond). 2024;20:17455057241227360.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.